Search

Your search keyword '"Bozovic Spasojevic, Ivana"' showing total 42 results
Start Over Author "Bozovic Spasojevic, Ivana"
42 results on '"Bozovic Spasojevic, Ivana"'

1. Advancing HER2-low breast cancer management: enhancing diagnosis and treatment strategies

Author

Borstnar Simona, Bozovic-Spasojevic Ivana, Cvetanovic Ana, Plavetic Natalija Dedic, Konsoulova Assia, Matos Erika, Popovic Lazar, Popovska Savelina, Tomic Snjezana, and Vrdoljak Eduard

Subjects
her2-low, metastatic breast cancer, balkans, testing, innovative treatment, access, Medical physics. Medical radiology. Nuclear medicine, R895-920
Abstract

Recent evidence brought by novel anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugates is leading to significant changes in HER2-negative breast cancer (BC) best practices. A new targetable category termed ‘HER2-low’ has been identified in tumors previously classified as ‘HER2-negative’. Daily practice in pathology and medical oncology is expected to align to current recommendations, but patient access to novel anticancer drugs across geographies might be impeded due to local challenges.

Published
2024
Full Text
View/download PDF

3. Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months

Author

de las Heras, Begoña, Saini, Kamal S., Boyle, Frances, Ades, Felipe, de Azambuja, Evandro, Bozovic-Spasojevic, Ivana, Romano, Marco, Capelan, Marta, Prasad, Rajeev, Pattu, Pugazhenthi, Massard, Christophe, Portera, Chia, Saini, Monika Lamba, Singh, Brajendra Prasad, Venkitaraman, Ramachandran, McNally, Richard, Leone, Manuela, Grande, Enrique, and Gupta, Sudeep

Published
2020
Full Text
View/download PDF

4. Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer

Author

Khan, Shah Zeb, Arecco, Luca, Villarreal-Garza, Cynthia, Sirohi, Bhawna, Ponde, Noam F., Habeeb, Baker, Brandão, Mariana, Azim, Hatem A., Jr, Chowdhury, Arman Reza, Bozovic-Spasojevic, Ivana, Kovalenko, Iryna, Odhiambo, Andrew, Seid, Fahmi Usman, Mutombo, Alex Baleka, Petracci, Fernando, Vidra, Radu, Altuna, Sara C., Petrova, Mila, Kourie, Hampig Raphael, Ozturk, Mehmet Akif, Razeti, Maria Grazia, Lengyel, Csongor György, Talibova, Narmin, Mariamidze, Elene, Sacardo, Karina Perez, Duma, Narjust, Gyawali, Bishal, Trapani, Dario, Tagliamento, Marco, and Lambertini, Matteo

Published
2022
Full Text
View/download PDF

5. Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey

Author

Bozovic Spasojevic, Ivana, primary, Ferrari, Andrea, additional, De Munter, Johan, additional, Gamble, Ashley, additional, Konsoulova-Kirova, Assia, additional, Rizvi, Katie, additional, Schneider, Carina, additional, Balsat, Marie, additional, Castleton, Anna, additional, Gofti-Laroche, Leila, additional, Kienesberger, Anita, additional, Timmermann, Beate, additional, Vormoor, Josef, additional, Saloustros, Emmanouil, additional, and Stark, Daniel P, additional

Published
2023
Full Text
View/download PDF

6. Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG)

Author

Schröder, Carolien P, primary, van Leeuwen-Stok, Elise, additional, Cardoso, Fatima, additional, Linderholm, Barbro, additional, Poncet, Coralie, additional, Wolff, Antonio C, additional, Bjelic-Radisic, Vesna, additional, Werutsky, Gustavo, additional, Abreu, Miguel H, additional, Bozovic-Spasojevic, Ivana, additional, den Hoed, Irma, additional, Honkoop, Aafke H, additional, Los, Maartje, additional, Leone, Jose P, additional, Russell, Nicola S, additional, Smilde, Tineke J, additional, van der Velden, Annette W G, additional, Van Poznak, Catherine, additional, Vleugel, Marije M, additional, Yung, Rachel L, additional, Coens, Corneel, additional, Giordano, Sharon H, additional, and Ruddy, Kathryn J, additional

Published
2023
Full Text
View/download PDF

7. Have we made progress in taking care of adolescents and young adults with cancer?: Results of a European multi-professional survey

Author

Onderzoek Beeld, Cancer, Bozovic Spasojevic, Ivana, Ferrari, Andrea, De Munter, Johan, Gamble, Ashley, Konsoulova-Kirova, Assia, Rizvi, Katie, Schneider, Carina, Balsat, Marie, Castleton, Anna, Gofti-Laroche, Leila, Kienesberger, Anita, Timmermann, Beate, Vormoor, Josef, Saloustros, Emmanouil, Stark, Daniel P, Onderzoek Beeld, Cancer, Bozovic Spasojevic, Ivana, Ferrari, Andrea, De Munter, Johan, Gamble, Ashley, Konsoulova-Kirova, Assia, Rizvi, Katie, Schneider, Carina, Balsat, Marie, Castleton, Anna, Gofti-Laroche, Leila, Kienesberger, Anita, Timmermann, Beate, Vormoor, Josef, Saloustros, Emmanouil, and Stark, Daniel P

Published
2023

8. Supplementary Table 2a and 2b from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure Figure 1A_1B from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure 2A from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 5 from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 6A from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 1 from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table 3 from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Tables and Figures legend from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table 4 from The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, primary, Brohée, Sylvain, primary, Ameye, Lieveke, primary, Fumagalli, Debora, primary, Ades, Felipe, primary, de Azambuja, Evandro, primary, Bareche, Yacine, primary, Piccart, Martine, primary, Paesmans, Marianne, primary, and Sotiriou, Christos, primary

Published
2023
Full Text
View/download PDF

17. Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)

Author

Ponde, Noam, Bradbury, Ian, Lambertini, Matteo, Ewer, Michael, Campbell, Christine, Ameels, Helene, Zardavas, Dimitrios, Di Cosimo, Serena, Baselga, José, Huober, Jens, Izquierdo, Miguel, Fumagalli, Debora, Bozovic-Spasojevic, Ivana, Maetens, Marion, Harbeck, Nadia, Pusztai, Lajos, Berghorn, Michael, Im, Young-Hyuck, Borrego, Manuel Ruiz, Chen, Dar-Ren, Rodeheffer, Richard, Piccart, Martine, Suter, Thomas, and de Azambuja, Evandro

Published
2017
Full Text
View/download PDF

20. Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network

Author

Morgan, Gilberto, Tagliamento, Marco, Lambertini, Matteo, Devnani, Bharti, Westphalen, Benedikt, Dienstmann, Rodrigo, Bozovic-Spasojevic, Ivana, Calles, A., Criscitiello, Carmen, Curioni, Alessandra, Garcia, Ariadna A.M., Lamarca, Angela, Pilotto, Sara, Scheffler, M., Strijbos, Michiel MH, Wong, Rachel, de Azambuja, Evandro, Peters, Solange, Morgan, Gilberto, Tagliamento, Marco, Lambertini, Matteo, Devnani, Bharti, Westphalen, Benedikt, Dienstmann, Rodrigo, Bozovic-Spasojevic, Ivana, Calles, A., Criscitiello, Carmen, Curioni, Alessandra, Garcia, Ariadna A.M., Lamarca, Angela, Pilotto, Sara, Scheffler, M., Strijbos, Michiel MH, Wong, Rachel, de Azambuja, Evandro, and Peters, Solange

Abstract

BACKGROUND: The COVID-19 pandemic has impacted all aspects of modern-day oncology, including how stakeholders communicate through social media. We surveyed oncology stakeholders in order to assess their attitudes pertaining to social media and how it has been affected during the pandemic. MATERIALS AND METHODS: A 40-item survey was distributed to stakeholders from 8 July to 22 July 2020 and was promoted through the European Society for Medical Oncology (ESMO) and the OncoAlert Network. RESULTS: One thousand and seventy-six physicians and stakeholders took part in the survey. In total, 57.3% of respondents were medical oncologists, 50.6% aged <40 years, 50.8% of female gender and mostly practicing in Europe (51.5%). More than 90% of respondents considered social media a useful tool for distributing scientific information and for education. Most used social media to stay up to date on cancer care in general (62.5%) and cancer care during COVID-19 (61%) given the constant flow of information. Respondents also used social media to interact with other oncologists (78.8%) and with patients (34.4%). Overall, 61.1% of respondents were satisfied with the role that social media was playing during the COVID-19 pandemic. On the other hand, 41.1% of respondents reported trouble in discriminating between credible and less credible information and 30% stated social networks were a source of stress. For this reason, one-third of respondents reduced its use during the COVID-19 pandemic. Regarding meeting attendance, a total of 59.1% of responding physicians preferred in-person meetings to virtual ones, and 51.8% agreed that virtual meetings and social distancing could hamper effective collaboration. CONCLUSION: Social media has a useful role in supporting cancer care and professional engagement in oncology. Although one-third of respondents reported reduced use of social media due to stress during the COVID-19 pandemic, the majority found social media useful to keep up to date and w, SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2021

21. Abstract OT-14-01: Adaption of the EORTC quality of life breast cancer module for male breast cancer - phase I

Author

Bjelic-Radisic, Vesna, primary, Cardoso, Fatima, additional, Weis, Joachim, additional, Bleiker, Eveline, additional, Cameron, David, additional, Velikova, Galina, additional, Pogoda, Karatzyna, additional, Serpentini, Samantha, additional, Punie, Kevin, additional, Yerushalmi, Rinat, additional, Matos, Erika, additional, Carly, Birgit, additional, Bozovic-Spasojevic, Ivana, additional, Fleisch, Markus, additional, Probst, Zoe Luisa, additional, Schafer, Sina Maria, additional, Russell, Nicola, additional, Tombeur, Sofie, additional, Vermeij, Joanna, additional, Roelstraete, Heidi, additional, Ruddy, Kathryn, additional, Arraras, Juan I, additional, and Bottomley, Andrew, additional

Published
2021
Full Text
View/download PDF

22. From presentation to paper: Gender disparities in oncological research

Author

Dijksterhuis, Willemieke P.M., primary, Stroes, Charlotte I., additional, Tan, Wan‐Ling, additional, Ithimakin, Suthinee, additional, Calles, Antonio, additional, Oijen, Martijn G.H., additional, Verhoeven, Rob H.A., additional, Barriuso, Jorge, additional, Oosting, Sjoukje F., additional, Ivankovic, Daniela Kolarevic, additional, Furness, Andrew J.S., additional, Bozovic‐Spasojevic, Ivana, additional, Gomez‐Roca, Carlos, additional, and Laarhoven, Hanneke W.M., additional

Published
2020
Full Text
View/download PDF

23. How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2)

Author

Montagna, Giacomo, Anderson, David, Bochenek-Cibor, Justyna, Bozovic-Spasojevic, Ivana, Campos, Conceicao, Cavallero, Sandro, Durutovic, Ivana, Gomez Cuadra, Manuel Oscar, Irfan, Tazia, Joly, Laetita, Kassem, Loay, Kolben, Theresa M., Machacek, Martina, Mir Khan, Benazir, Nagvekar, Mayur, Pellegrino, Benedetta, Pogoda, Katarzyna, Câmara, Gabriela Rodrigues, Ferreira, Pedro Santos, Seferi, Melsi, Talibova, Narmin, Van den Rul, Nathalie, Vettus, Elen, and Rocco, Nicola

Published
2019
Full Text
View/download PDF

24. Treatment outcome in patients with breast conserving surgery after neoadjuvant therapy for breast carcinoma – a single institution experience

Author

Martinovic Aleksandar, Bozovic-Spasojevic Ivana, Nikolic Srdjan, Markovic Ivan, Lukic Branko, Gavrilovic Dusica, Granic Miroslav, and Dzodic Radan

Subjects
body regions, endocrine system, fungi, outcome, neoadjuvant therapy, breast conserving surgery
Abstract

PURPOSE: The aim of this study was to analyze outcomes of breast conserving surgery (BCS) after neoadjuvant treatment (NAT) in comparison to radical mastectomy (RM) after NAT in terms of disease-free survival (DFS), overall survival (OS) and patients' satisfaction with the esthetic outcomes of surgery. METHODS: This prospective study was conducted at the National Cancer Research Center of Serbia, Belgrade, from January 1st 2011 to December 31st 2015, on breast carcinoma patients receiving NAT. Treatment outcome was assessed by MDAPI (MD Anderson Prognostic Index). Female patients (n=52) with satisfactory clinical response to NAT and MDAPI scores 0 or 1 were included into the treatment group (NAT-BCS group). The control group (NAT-RM group) consisted of patients (n=52) with poorer clinical response and MDAPI scores 2 to 4. On check-ups, local or distant relapses were noted and both groups were asked to value their satisfaction with the esthetic outcomes of surgery using the Likert scale. RESULTS: OS was 100% in both groups. DFS was 96.1% in NAT-BCS group and 100% in NAT-RM group. Local recurrences were observed in two patients from the age group ≥60 years, with initial disease stage IIIA and "clear" resection margins on frozen section study. Patients in the NAT-BCS group were more satisfied with the esthetic outcome of surgery than the control group. CONCLUSIONS: BCS after NAT provides good esthetic outcome and is oncologically safe if adequate clinical response is achieved after NAT and if established criteria for patient selection are followed.

Published
2018
Full Text
View/download PDF

25. The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

Author

Bozovic-Spasojevic, Ivana, primary, Zardavas, Dimitrios, additional, Brohée, Sylvain, additional, Ameye, Lieveke, additional, Fumagalli, Debora, additional, Ades, Felipe, additional, de Azambuja, Evandro, additional, Bareche, Yacine, additional, Piccart, Martine, additional, Paesmans, Marianne, additional, and Sotiriou, Christos, additional

Published
2017
Full Text
View/download PDF

26. The prognostic role of androgen receptor in patients with early stage breast cancer: A meta-analysis of clinical and gene expression data.

Author

Bozovic-Spasojevic, Ivana, Zardavas, Dimitrios, Brohée, Sylvain, Ameye, Lieveke, Fumagalli, Debora, Ades Moraes, Felipe, de Azambuja, Evandro, Bareche, Yacine, Piccart-Gebhart, Martine, Paesmans, Marianne, Sotiriou, Christos, Bozovic-Spasojevic, Ivana, Zardavas, Dimitrios, Brohée, Sylvain, Ameye, Lieveke, Fumagalli, Debora, Ades Moraes, Felipe, de Azambuja, Evandro, Bareche, Yacine, Piccart-Gebhart, Martine, Paesmans, Marianne, and Sotiriou, Christos

Abstract

Androgen receptor (AR) expression has been observed in about 70% of breast cancer (BC) patients, but its prognostic role remains uncertain., SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2017

27. A European Network for Teenagers and Young Adults with Cancer.

Author

Bozovic-Spasojevic, Ivana, Balsat, Marie, Blondeel, Anne, Castleton, Anna, De Munter, Johan, Gamble, Ashley S., Kienesberger, Anita, Konsoulova-Kirova, Assia Andrianova, Rizvi, Katie, Schneider, Carina, Vermeersch, Josefien, Ferrari, Andrea, and Stark, Daniel

Subjects
*TUMORS in children, *CANCER patient medical care
Published
2021
Full Text
View/download PDF

31. Young patients with breast cancer: Comparison of molecular characteristics of pregnancy associated breast cancer with non-pregnancy associated breast cancer.

Author

Tomasevic, Zorica, primary, Tomasevic, Zoran, additional, Kovac, Zeljko, additional, Milovanovic, Zorka, additional, Minic, Ivana, additional, Milosevic, Snezana, additional, Bozovic-Spasojevic, Ivana, additional, Zdrale, Zdravko, additional, Markovic, Ivan, additional, and Dzodic, Radan, additional

Published
2015
Full Text
View/download PDF

33. PO59 DURABLE REMISSIONS WITH TRASTUZUMAB TREATMENT FOR HER2 POSITIVE METASTATIC BREAST CANCER – SINGLE CENTER EXPERIENCE

Author

Aleksandra Sarcevic, Zoran Tomasevic, Daniela Kolarevic, Dobrica Neric, Zorica Tomasevic, Bozovic-Spasojevic Ivana, S. Milosevic, and Zdrale Zdravko

Subjects
Oncology, medicine.medical_specialty, Trastuzumab, business.industry, Internal medicine, medicine, Surgery, General Medicine, medicine.disease, Single Center, business, Metastatic breast cancer, medicine.drug
Published
2015
Full Text
View/download PDF

35. The prognostic role of androgen receptor in early-stage breast cancer patients: A meta-analysis.

Author

ASCO Annual Meeting (2013 May 31-June 4: Chicago, USA), Bozovic-Spasojevic, Ivana, Zardavas, Dimitrios, de Azambuja, Evandro, Ameye, L., Sotiriou, Christos, Piccart-Gebhart, Martine, Paesmans, Marianne, ASCO Annual Meeting (2013 May 31-June 4: Chicago, USA), Bozovic-Spasojevic, Ivana, Zardavas, Dimitrios, de Azambuja, Evandro, Ameye, L., Sotiriou, Christos, Piccart-Gebhart, Martine, and Paesmans, Marianne

Abstract

info:eu-repo/semantics/nonPublished

Published
2013

42. Treatment outcome in patients with breast conserving surgery after neoadjuvant therapy for breast carcinoma - a single institution experience.

Author

Martinovic A, Santrac N, Bozovic-Spasojevic I, Nikolic S, Markovic I, Lukic B, Gavrilovic D, Granic M, and Dzodic R

Subjects
Breast Neoplasms pathology, Female, Humans, Middle Aged, Prospective Studies, Treatment Outcome, Breast Neoplasms drug therapy, Breast Neoplasms surgery, Neoadjuvant Therapy methods
Abstract

Purpose: The aim of this study was to analyze outcomes of breast conserving surgery (BCS) after neoadjuvant treatment (NAT) in comparison to radical mastectomy (RM) after NAT in terms of disease-free survival (DFS), overall survival (OS) and patients' satisfaction with the esthetic outcomes of surgery., Methods: This prospective study was conducted at the National Cancer Research Center of Serbia, Belgrade, from January 1st 2011 to December 31st 2015, on breast carcinoma patients receiving NAT. Treatment outcome was assessed by MDAPI (MD Anderson Prognostic Index). Female patients (n=52) with satisfactory clinical response to NAT and MDAPI scores 0 or 1 were included into the treatment group (NAT-BCS group). The control group (NAT-RM group) consisted of patients (n=52) with poorer clinical response and MDAPI scores 2 to 4. On check-ups, local or distant relapses were noted and both groups were asked to value their satisfaction with the esthetic outcomes of surgery using the Likert scale., Results: OS was 100% in both groups. DFS was 96.1% in NAT-BCS group and 100% in NAT-RM group. Local recurrences were observed in two patients from the age group ≥60 years, with initial disease stage IIIA and "clear" resection margins on frozen section study. Patients in the NAT-BCS group were more satisfied with the esthetic outcome of surgery than the control group., Conclusions: BCS after NAT provides good esthetic outcome and is oncologically safe if adequate clinical response is achieved after NAT and if established criteria for patient selection are followed.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results